Nuwellis, Inc. (NUWE)
NASDAQ: NUWE · Real-Time Price · USD
4.180
-0.030 (-0.71%)
At close: Sep 12, 2025, 4:00 PM EDT
4.190
+0.010 (0.24%)
After-hours: Sep 12, 2025, 7:56 PM EDT
Nuwellis Revenue
Nuwellis had revenue of $1.73M in the quarter ending June 30, 2025, a decrease of -21.38%. This brings the company's revenue in the last twelve months to $8.32M, down -7.72% year-over-year. In the year 2024, Nuwellis had annual revenue of $8.74M, down -1.40%.
Revenue (ttm)
$8.32M
Revenue Growth
-7.72%
P/S Ratio
0.03
Revenue / Employee
$218,895
Employees
38
Market Cap
3.77M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 8.74M | -124.00K | -1.40% |
Dec 31, 2023 | 8.86M | 321.00K | 3.76% |
Dec 31, 2022 | 8.54M | 622.00K | 7.85% |
Dec 31, 2021 | 7.92M | 480.00K | 6.45% |
Dec 31, 2020 | 7.44M | 1.93M | 35.02% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
NUWE News
- 3 days ago - Nuwellis' Vivian Receives $3 Million NIH Grant to Accelerate Pediatric Platform and Strengthen Fluid-Management Portfolio - GlobeNewsWire
- 8 days ago - Nuwellis Introduces New 24-Hour Aquadex™ Circuit to Support Hospital-Based Outpatient and Short-Term Fluid Management - GlobeNewsWire
- 22 days ago - Nuwellis Receives FDA 510(k) Clearance for New Dual Lumen Extended Length Catheter - GlobeNewsWire
- 24 days ago - Nuwellis Signs Letter of Intent to Explore Acquisition of Rendiatech Ltd., A Real-Time Fluid Monitoring Company - GlobeNewsWire
- 4 weeks ago - Nuwellis, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech - GlobeNewsWire
- 4 weeks ago - Nuwellis, Inc. (NUWE) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Nuwellis, Inc. Reports Second Quarter 2025 Financial Results and Business Highlights - GlobeNewsWire
- 5 weeks ago - Nuwellis to Exit International Operations to Accelerate U.S. Revenue Growth and Strategic Focus - GlobeNewsWire